Affiliation:
1. From Unité INSERM U36, Collège de France and Laboratoire de Génétique Moléculaire, Hôpital Broussais, Paris (A.P., A.-M.H., P.C., X.J.); and Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, UPR 411, Sophia Antipolis (P.B., F.B., R.M., M.L.), France.
Abstract
Abstract
—Mutations of the last exon of the β subunit of the amiloride-sensitive epithelial Na
+
channel (βENaC) can lead to Liddle’s syndrome, a rare monogenic form of hypertension. The objective of this study was to test whether more subtle changes of βENaC could be implicated in essential hypertension. After determination of the βENaC coding gene organization (12 exons spanning 23.5 kb), a systematic screening of the last exon of the gene was performed in 525 subjects (475 whites, 50 Afro-Caribbeans), all probands of hypertensive families. This search was extended to the remaining 11 exons in a subset of 101 probands with low-renin hypertension. Seven amino acid changes were detected: G589S, T594M, R597H, R624C, E632G (last exon), G442V, and V434M (exon 8). These genetic variants were more frequent in subjects of African origin (44%) than in whites (1%). The functional properties of the variants were analyzed in
Xenopus
oocytes by two independent techniques, ie, electrophysiology and
22
Na
+
uptake. Small but not significant differences were observed between the variants and wild type. The clinical evaluation of the family bearing the G589S variant, which provided the highest relative ENaC activity, did not show a cosegregation between the mutation and hypertension. The present study illustrates the difficulty in establishing a relation of causality between a susceptibility gene and hypertension. Furthermore, it does not favor a substantial role of the βENaC gene in essential hypertension.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献